{
    "url_original": "https://www.wsj.com/articles/merck-asks-fda-to-authorize-promising-covid-19-pill-11633946402?mod=business_lead_pos1",
    "url": "merck-asks-fda-to-authorize-promising-covid-19-pill-11633946402",
    "title": "Merck Asks FDA to Authorize Promising Covid-19 Pill",
    "sub_head": "The drug could fill a big need for a pill that patients could easily take at home to help avoid hospitalization",
    "category_1": "Business",
    "category_2": "Health Care",
    "image_1_url": "https://images.wsj.net/im-414753?width=860&height=573",
    "image_1": "im-414753.jpg",
    "time": "2021-10-11 06:00:00",
    "body": "Merck & Co. and partner Ridgeback Biotherapeutics LP said Monday they have filed an application asking U.S. health regulators to authorize their Covid-19 pill, the next step toward adding a long-sought drug for use at home.<br />The filing comes shortly after data from a late-stage study showed that the antiviral drug, molnupiravir, cut the risk of hospitalization or death by about 50% in high-risk people with mild to moderate Covid-19."
}